Twenty-Four Vs. Fourty-Eight Weeks of Re-Therapy With Interferon Alpha 2b and Ribavirin in Interferon Alpha Monotherapy Relapsers With Chronic Hepatitis C. Swiss Med Wkly 2003, 133 (3334), 455-460. https://doi.org/10.4414/smw.2003.10300.